NO160474C - Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener. - Google Patents

Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener.

Info

Publication number
NO160474C
NO160474C NO821431A NO821431A NO160474C NO 160474 C NO160474 C NO 160474C NO 821431 A NO821431 A NO 821431A NO 821431 A NO821431 A NO 821431A NO 160474 C NO160474 C NO 160474C
Authority
NO
Norway
Prior art keywords
antigen
antigens
detection
detailable
determination
Prior art date
Application number
NO821431A
Other languages
English (en)
Norwegian (no)
Other versions
NO160474B (no
NO821431L (no
Inventor
Robertus Carolus Aalberse
Original Assignee
Stichting Centr Lab V Bloedtra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19837436&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO160474(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Centr Lab V Bloedtra filed Critical Stichting Centr Lab V Bloedtra
Publication of NO821431L publication Critical patent/NO821431L/no
Publication of NO160474B publication Critical patent/NO160474B/no
Publication of NO160474C publication Critical patent/NO160474C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO821431A 1981-05-02 1982-04-30 Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener. NO160474C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8102178A NL8102178A (nl) 1981-05-02 1981-05-02 Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.

Publications (3)

Publication Number Publication Date
NO821431L NO821431L (no) 1982-11-03
NO160474B NO160474B (no) 1989-01-09
NO160474C true NO160474C (no) 1989-04-19

Family

ID=19837436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821431A NO160474C (no) 1981-05-02 1982-04-30 Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener.

Country Status (12)

Country Link
US (1) US4468470A (de)
EP (1) EP0064318B1 (de)
JP (1) JPS589071A (de)
AT (1) ATE15274T1 (de)
AU (1) AU8317482A (de)
CA (1) CA1177391A (de)
DE (1) DE3265768D1 (de)
DK (1) DK155967C (de)
ES (1) ES8304314A1 (de)
IE (1) IE53059B1 (de)
NL (1) NL8102178A (de)
NO (1) NO160474C (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
GB8422452D0 (en) * 1984-09-05 1984-10-10 Serono Diagnostics Ltd Assay
US4806311A (en) * 1985-08-28 1989-02-21 Miles Inc. Multizone analytical element having labeled reagent concentration zone
US5262334A (en) * 1986-01-30 1993-11-16 Fred Hutchinson Cancer Research Center Method for immunoselection of cells using avidin and biotin
US5225353A (en) * 1986-01-30 1993-07-06 Fred Hutchinson Cancer Research Center Method for immunoselection of cells using avidin and biotin
JP2505179B2 (ja) * 1986-12-16 1996-06-05 日本碍子株式会社 高強度常圧焼結窒化珪素焼結体およびその製造方法
US4859612A (en) * 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
DE4140142A1 (de) * 1991-12-05 1993-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim, De Multivalentes dextranreagenz zum einsatz in praezipitationstests
US5518882A (en) * 1993-12-21 1996-05-21 Biotex Laboratories, Inc. Immunological methods of component selection and recovery
FR2716263B1 (fr) * 1994-02-11 1997-01-17 Pasteur Institut Procédé d'alignement de macromolécules par passage d'un ménisque et applications dans un procédé de mise en évidence, séparation et/ou dosage d'une macromolécule dans un échantillon.
DE4434093A1 (de) * 1994-09-23 1996-03-28 Boehringer Mannheim Gmbh Verfahren zum qualitativen oder/und quantitativen Nachweis einer zu bestimmenden Substanz
US5773224A (en) * 1996-02-12 1998-06-30 Grandics; Peter Immunoselection system for cell elution
US6436722B1 (en) * 2000-04-18 2002-08-20 Idexx Laboratories, Inc. Device and method for integrated diagnostics with multiple independent flow paths
EP1195606A1 (de) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-Assay auf Basis von Mikroanordnungen
ATE538380T1 (de) * 2001-01-23 2012-01-15 Harvard College Nukleinsäure-programmierbare protein-arrays
DE10327066A1 (de) * 2002-11-29 2004-09-16 Max-Delbrück-Centrum für Molekulare Medizin Bestimmung agonistischer Autoantikörper
US7741050B2 (en) * 2002-11-29 2010-06-22 Max-Delbrueck-Centrum fuer Molkulare Medizin Identification of agonistic autoantibodies
WO2005108615A2 (en) * 2004-04-14 2005-11-17 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
US8178316B2 (en) * 2006-06-29 2012-05-15 President And Fellows Of Harvard College Evaluating proteins
WO2017087798A1 (en) 2015-11-18 2017-05-26 Formycon Ag Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341239B (de) * 1967-09-06 1971-12-20 Pharmacia Ab
US3773625A (en) * 1971-04-08 1973-11-20 Us Army Soluble antigen-antibody complexes
US3966898A (en) * 1973-06-28 1976-06-29 Pharmacia Diagnostics Ab Method and reagent for determining immunologic materials
US4230797A (en) * 1975-04-28 1980-10-28 Miles Laboratories, Inc. Heterogenous specific binding assay employing a coenzyme as label
US4021534A (en) * 1975-12-12 1977-05-03 Hoffmann-La Roche Inc. Radioimmunoassay
SE427505B (sv) * 1977-03-04 1983-04-11 Pharmacia Diagnostics Ab Reagens till anvendning vid immunkemiska bestemningsmetoder
IL51667A (en) * 1977-03-16 1979-10-31 Miles Yeda Ltd Immunoassay for the determination of a hapten
US4271140A (en) * 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
US4228237A (en) * 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
US4495296A (en) * 1979-05-21 1985-01-22 New York Blood Center, Inc. Labeled anti-hapten antibodies and their use as a universal reagent for solid phase radio- and/or enzyme-immunoassays

Also Published As

Publication number Publication date
ES512498A0 (es) 1983-02-16
JPS589071A (ja) 1983-01-19
DE3265768D1 (en) 1985-10-03
AU8317482A (en) 1982-11-11
DK155967C (da) 1989-10-16
EP0064318B1 (de) 1985-08-28
DK196282A (da) 1982-11-03
NO160474B (no) 1989-01-09
NL8102178A (nl) 1982-12-01
NO821431L (no) 1982-11-03
US4468470A (en) 1984-08-28
CA1177391A (en) 1984-11-06
EP0064318A1 (de) 1982-11-10
IE53059B1 (en) 1988-05-25
ATE15274T1 (de) 1985-09-15
DK155967B (da) 1989-06-05
ES8304314A1 (es) 1983-02-16

Similar Documents

Publication Publication Date Title
NO160474C (no) Fremgangsmaate og sett for paavisning og bestemmelse av antistoffer mot opploeselige antigener.
EP0303110B1 (de) Immundiagnostische Vorrichtung und zugehöriges Verfahren
DK343679A (da) Immunologisk fremgangsmaade til bestemmelse af et immunkompleks i en vaeske samt det ved frmegangsmaaden anvendte diagnostiske middel
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ES2009939A6 (es) Un inmunoensayo para la deteccion simultanea de antigenos yno anticuerpos en una muestra a ensayar de un fluido fisiologico.
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
ES520012A0 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
SE7606082L (sv) Forfarande for pavisande av antikroppar i kroppsvetskor med hjelp av kenda antigener eller for bestemning av antigener med hjelp av kenda antikroppar ur kroppvetskor
ES2061324T3 (es) Complejo aglutinante como reactivo de identificacion de grupo sanguineo.
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
ATE64466T1 (de) Immuntest.
ATE14799T1 (de) Verfahren zur feststellung sehr geringer antigen- und antikoerpermengen nach einem agglutinations- hemmungstest.
Drevin et al. Covalent coupling of proteins to erythrocytes by isocyanide. A new, sensitive and mild technique for identification and estimation of antibodies by passive hemagglutination
DE3781808T2 (de) Diagnosetestverfahren fuer schweinedysenterie.
FI104219B1 (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
RU94020434A (ru) Способ и набор для обнаружения вируса лихорадки долины рифт и антител к нему в биологических материалах
KR890702040A (ko) 요중의 염기성 태아단백의 측정방법 및 그것에 사용되는 측정키트
DE68917732D1 (de) Immuntestverfahren von chondrocalcin.
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns